EUVIMEDEUVIMED entdecken
Crossref

A comparative study of intrathecal dexmedetomidine and fentanyl as additives to bupivacaine

Wafaa Ahmed, Ahmed El-Attar, MohamedAbdel Aleem, Ragab Beltagy

Research and Opinion in Anesthesia and Intensive Care · 2015 · 1 (1) · 43

DOI: 10.4103/2356-9115.161328 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research and Opinion in Anesthesia and Intensive Care, 2015. Verfasst von Wafaa Ahmed und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In recent years, the use of intrathecal adjuvants has gained popularity. The quality of spinal anesthesia has been reported to improve with the addition of opioids and other drugs, but until now there is no single drug with no side effects. The aim of this study was to compare the addition of either dexmedetomidine or fentanyl to intrathecal bupivacaine as regards the onset and duration of sensory and motor block, hemodynamic effects, postoperative analgesia, and adverse effects of either drug. Materials and methods Sixty patients classified in American Society of Anesthesiologists as classes I and II scheduled for lower abdominal and lower limb surgeries were studied. Patients were randomly allocated to three groups (20 patients each): group B, group F, and group D. Group B patients received 3 ml (15 mg) of 0.5% hyperbaric bupivacaine plus 0.5 ml of normal saline intrathecally. Group F patients received 3 ml (15 mg) of 0.5% hyperbaric bupivacaine plus 0.5 ml (25 μg) of preservative-free fentanyl intrathecally. Group D patients received 3 ml (15 mg) of 0.5% hyperbaric bupivacaine plus 0.5 ml (5 μg) of diluted, preservative-free dexmedetomidine intrathecally.

Results

Patients in the dexmedetomidine group (D) had faster sensory and motor onsets compared with those in the fentanyl group (F) and the bupivacaine group (B) (P = 0.000 for both sensory and motor). Patients in group D had significantly longer sensory and motor durations compared with those in groups F and B (P = 0.000). Patients in the dexmedetomidine group (D) did not have significant hemodynamic changes; they had prolonged analgesic effect with less 24 h requirements of analgesics, and they had nonsignificant adverse effects.

Conclusion

Dexmedetomidine has faster onset compared with fentanyl and bupivacaine when injected intrathecally along with bupivacaine; it prolonged the sensory and motor blocks and was hemodynamically stable, with no significant side effects and with less requirements of postoperative analgesic needs during the first 24h.

Zitieren

APA

Ahmed, W., El-Attar, A., Aleem, M., & Beltagy, R. (2015). A comparative study of intrathecal dexmedetomidine and fentanyl as additives to bupivacaine. Research and Opinion in Anesthesia and Intensive Care, 1(1), 43. https://doi.org/10.4103/2356-9115.161328

Vancouver

Ahmed W, El-Attar A, Aleem M, Beltagy R. A comparative study of intrathecal dexmedetomidine and fentanyl as additives to bupivacaine. Research and Opinion in Anesthesia and Intensive Care. 2015;1(1):43. doi:10.4103/2356-9115.161328

BibTeX
@article{Ahmed2015,
  author = {Ahmed, Wafaa and El-Attar, Ahmed and Aleem, MohamedAbdel and Beltagy, Ragab},
  title = {A comparative study of intrathecal dexmedetomidine and fentanyl as additives to bupivacaine},
  journal = {Research and Opinion in Anesthesia and Intensive Care},
  year = {2015},
  volume = {1},
  number = {1},
  pages = {43},
  doi = {10.4103/2356-9115.161328}
}
Kostenlos starten →